7-(3-trifluoromethylphenyl)-7-hydroxyheptanoic acid | 103196-90-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 7-(3-trifluoromethylphenyl)-7-hydroxyheptanoic acid
• 英文别名: 7-hydroxy-7-[3-(trifluoromethyl)phenyl]heptanoic acid
• CAS: 103196-90-3
• 化学式: C₁₄H₁₇F₃O₃
• 分子量: 290.282
• InChiKey: XNYXNWKTSMWOKU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  20
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  7-(3-trifluoromethylphenyl)-7-hydroxyheptanoic acid 在 三氟化硼乙醚 、 三氯化铁 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 反应 2.0h， 生成 7-(3-trifluoromethylphenyl)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)heptanoic acid
  参考文献：
  名称：

  Quinones. 4. Novel eicosanoid antagonists: synthesis and pharmacological evaluation

  摘要：

  A new series of omega-phenyl-omega-quinonylalkanoic acids and related compounds was synthesized. The compounds were tested for their inhibitory effects on U-44069-induced contraction of the rabbit aorta. (+/- )-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid (4d) (AA-2414) with pA2 value of 8.28 was one of the most potent compounds. Compound 4d inhibited U-46619-induced contraction of the guinea pig lung (pA2 = 8.29) and U-44069-induced aggregation of the guinea pig platelet (IC50 = 3.5 x 10(-7) M). Compound 4d displaced the binding of [3H]U-46619 to guinea pig platelets (IC50 = 7.4 x 10(-9) M). Compound 4d also showed very potent inhibitory effects with an MED of 0.3 mg/kg (po) on U-46619-, LTD4-, PAF-, or IgG1-induced bronchoconstriction in guinea pigs. The enantiomers of 4d were prepared. The R-(+) isomer 8a was active in both in vitro and in vivo tests, but the S-(-) isomer 8b was much less active. We concluded that the antiasthmatic effects of 4d were based mainly on the TXA2 receptor antagonistic action. In addition, compound 4d showed potent inhibitory effects on PGD2-, PGF2 alpha-, and 11-epi-PGF2 alpha-induced contraction of the guinea pig tracheal strips. The diverse inhibitory effects might be expressed in terms of eicosanoid-antagonistic activity.

  DOI：

  10.1021/jm00129a030
• 作为产物：
  描述：

  乙基7-氧代-7-[3-(三氟甲基)苯基]庚酸酯 在 sodium hydroxide 、 sodium tetrahydroborate 作用下， 生成 7-(3-trifluoromethylphenyl)-7-hydroxyheptanoic acid
  参考文献：
  名称：

  Quinones. 4. Novel eicosanoid antagonists: synthesis and pharmacological evaluation

  摘要：

  A new series of omega-phenyl-omega-quinonylalkanoic acids and related compounds was synthesized. The compounds were tested for their inhibitory effects on U-44069-induced contraction of the rabbit aorta. (+/- )-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid (4d) (AA-2414) with pA2 value of 8.28 was one of the most potent compounds. Compound 4d inhibited U-46619-induced contraction of the guinea pig lung (pA2 = 8.29) and U-44069-induced aggregation of the guinea pig platelet (IC50 = 3.5 x 10(-7) M). Compound 4d displaced the binding of [3H]U-46619 to guinea pig platelets (IC50 = 7.4 x 10(-9) M). Compound 4d also showed very potent inhibitory effects with an MED of 0.3 mg/kg (po) on U-46619-, LTD4-, PAF-, or IgG1-induced bronchoconstriction in guinea pigs. The enantiomers of 4d were prepared. The R-(+) isomer 8a was active in both in vitro and in vivo tests, but the S-(-) isomer 8b was much less active. We concluded that the antiasthmatic effects of 4d were based mainly on the TXA2 receptor antagonistic action. In addition, compound 4d showed potent inhibitory effects on PGD2-, PGF2 alpha-, and 11-epi-PGF2 alpha-induced contraction of the guinea pig tracheal strips. The diverse inhibitory effects might be expressed in terms of eicosanoid-antagonistic activity.

  DOI：

  10.1021/jm00129a030

文献信息

• Quinone derivatives, their production and use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05180742A1

  公开（公告）日：1993-01-19

  Quinone derivatives of the general formula: ##STR1## (wherein R.sup.1 and R.sup.2 are the same or different, and independently are a hydrogen atom or a methyl or methoxy group, or R.sup.1 and R.sup.2 combine with each other to represent --CH.dbd.CH--CH.dbd.CH--R.sup.3 is a hydrogen atom or a methyl group; R.sup.4 is an aliphatic, aromatic or heterocyclic group which may be substituted; R.sup.5 is a methyl or methoxy group, a hydroxymethyl group which may be substituted or a carboxyl group which may be esterified or amidated; Z is a group represented by --C.dbd.C--, --CH.dbd.CH--, ##STR2## n is an integer of 0 to 10; m is an integer of 0 to 3; k is an integer of 0 to 5, provided, however, that in the case of m being 2 or 3, Z and k can vary arbitrarily within the bracketed repeating units) are novel compounds, possess metabolism ameliorating action for polyunsaturated fatty acids, particularly production inhibitory activity of lipid peroxides (antioxidant activity), thromboxane A.sub.2 receptor antagonism, or production inhibitory activity of 5-lipoxygenase metabolites in mammals, and of use as drugs, such as antiasthmatic, antiallergic agent and cerebral-circulatory metabolism ameliorating agent.

  通式为：##STR1##的醌衍生物（其中R.sup.1和R.sup.2相同或不同，且独立地为氢原子或甲基或甲氧基，或R.sup.1和R.sup.2结合在一起表示--CH.dbd.CH--CH.dbd.CH--R.sup.3为氢原子或甲基；R.sup.4为可以被取代的脂肪、芳香或杂环基团；R.sup.5为甲基或甲氧基、可以被取代的羟甲基或可以酯化或酰胺化的羧基；Z为--C.dbd.C--，--CH.dbd.CH--，##STR2##所表示的基团；n为0到10的整数；m为0到3的整数；k为0到5的整数，但是在m为2或3的情况下，Z和k可以在括号内的重复单元中任意变化）是新颖的化合物，具有改善多不饱和脂肪酸代谢的作用，特别是对脂质过氧化物的产生抑制活性（抗氧化活性）、血栓素A.sub.2受体拮抗作用，或对哺乳动物中5-脂氧合酶代谢产物的产生抑制活性，并可用作药物，如抗哮喘、抗过敏剂和改善脑循环代谢的药剂。
• US5180742A
  申请人：——

  公开号：US5180742A

  公开（公告）日：1993-01-19
• US5304658A
  申请人：——

  公开号：US5304658A

  公开（公告）日：1994-04-19
• Quinones. 4. Novel eicosanoid antagonists: synthesis and pharmacological evaluation
  作者：Mitsuru Shiraishi、Kaneyoshi Kato、Shinji Terao、Yasuko Ashida、Zenichi Terashita、Go Kito

  DOI：10.1021/jm00129a030

  日期：1989.9

  A new series of omega-phenyl-omega-quinonylalkanoic acids and related compounds was synthesized. The compounds were tested for their inhibitory effects on U-44069-induced contraction of the rabbit aorta. (+/- )-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid (4d) (AA-2414) with pA2 value of 8.28 was one of the most potent compounds. Compound 4d inhibited U-46619-induced contraction of the guinea pig lung (pA2 = 8.29) and U-44069-induced aggregation of the guinea pig platelet (IC50 = 3.5 x 10(-7) M). Compound 4d displaced the binding of [3H]U-46619 to guinea pig platelets (IC50 = 7.4 x 10(-9) M). Compound 4d also showed very potent inhibitory effects with an MED of 0.3 mg/kg (po) on U-46619-, LTD4-, PAF-, or IgG1-induced bronchoconstriction in guinea pigs. The enantiomers of 4d were prepared. The R-(+) isomer 8a was active in both in vitro and in vivo tests, but the S-(-) isomer 8b was much less active. We concluded that the antiasthmatic effects of 4d were based mainly on the TXA2 receptor antagonistic action. In addition, compound 4d showed potent inhibitory effects on PGD2-, PGF2 alpha-, and 11-epi-PGF2 alpha-induced contraction of the guinea pig tracheal strips. The diverse inhibitory effects might be expressed in terms of eicosanoid-antagonistic activity.